Eight-weeks of glecaprevir/pibrentasvir is well tolerated and yields high sustained virological response in HCV-infected treatment-naive patients with compensated cirrhosis: the CREST study

Subjects

Subjects :

Hepatology

Details

ISSN :

01688278

Volume :

77

Database :

OpenAIRE

Journal :

Journal of Hepatology

Accession number :

edsair.doi...........a61da43718f1031177033b9ed73e1106

Full Text :

https://doi.org/10.1016/s0168-8278(22)01486-6